Company attributes
Location
Total Funding Amount (USD)
90,000,000
Latest Funding Round Date
October 26, 2017
Competitors
CTO
Other attributes
Company Operating Status
Closed
Impact Biomedicines was acquired by Celgene in January 2018. Celgene was in turn acquired by Bristol Myers Squibb in November 2019.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
